Senior Health Channel
Topics & Medications
Quicklinks
Related Channels

Generic Pneumovax

Pneumovax (pneumococcal polysaccharide vaccine) is considered a "biologic" medication, which means that it is regulated somewhat differently than other drugs. Because of the rules and regulations surrounding the vaccine, generic versions of Pneumovax are not allowed to be made at this time. However, these laws are changing, possibly allowing for a generic version to be sold in the not-too-distant future.

Can I Buy Generic Pneumovax?

Pneumovax® (pneumococcal polysaccharide vaccine) is a vaccine used to prevent pneumonia and other serious pneumococcal diseases. It is approved for use in people who are at least two years old.
 
Pneumovax is made by Merck & Co., Inc. There are no generic versions of Pneumovax. The other pneumococcal vaccines available (Prevnar®, Prevnar 13®), which are usually used in infants, are not interchangeable with Pneumovax.
 
Technically, Pneumovax is considered a "biologic" medication -- this means it is under different rules and laws than most other medications. At this point, generic biologics, including generic Pneumovax, are not allowed to be made. However, the laws are changing, and it is likely that generic biologics will be permitted in the near future.
 

Understanding Biologics and Generics

When the patents for regular drugs expire, other manufacturers can apply to make generic versions. These companies need to submit a little information proving that their product is equivalent to the brand-name drug, but they do not have to repeat all of the human studies to show the drug to be safe and effective.
 
Human studies are expensive and time-consuming, and generic medications are less expensive because they do not need all the human studies.
 
However, biologics (medications made using live cells or organisms, also known as "biopharmaceuticals") are regulated under a different set of laws. Under these laws, there is no way for a generic biologic to be approved unless the generic manufacturer completes all of the human studies necessary to approve a brand-new drug.
 
Because such studies are extremely expensive, it is likely that a generic biologic would not be any less expensive than the brand-name product. Essentially, if a generic biologic were to be approved, it would not really be a generic, but a new and separate drug that would not be equivalent to the brand-name product. Recent legislation is aimed at changing these laws, and it is predicted that new laws and regulations will allow generic biologics in the near future.
 
Warning: 10 Hidden Sources of Lactose

Pneumovax Vaccine Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.